Adventist Healthcare, INC.
Adventist Healthcare, INC. was paid $9.70M by Medicaid between Jan 2018 and Dec 2024, across 112 billing codes. Its largest line is 41899, Unlisted procedure, dentoalveolar structures — 49% of everything it billed.
ROCKVILLE, MD 20850
Next to other General Acute Care Hospital providers in Maryland
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 32,116 | $3.75M | |
| 2019 | 30,480 | $3.30M | |
| 2020 | 17,601 | $457K | |
| 2021 | 19,787 | $567K | |
| 2022 | 21,453 | $666K | |
| 2023 | 18,606 | $548K | |
| 2024incomplete | 13,015 | $416K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 41899 | Unlisted procedure, dentoalveolar structures | 49% | 1,534 | 1,502 | $4.77M |
| G0378 | Hospital observation service, per hour | 16% | 3,179 | 2,921 | $1.60M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 15% | 9,302 | 8,256 | $1.49M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 11% | 9,380 | 8,261 | $1.07M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 3.6% | 1,525 | 1,366 | $349K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 1,616 | 1,487 | $85K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 2,097 | 1,542 | $58K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 133 | 77 | $41K |
| 80053 | Comprehensive metabolic panel | <1% | 13,553 | 10,863 | $33K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,033 | 1,868 | $29K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 16,597 | 11,852 | $20K |
| 87070 | <1% | 271 | 251 | $16K |
100 more codes
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 72 | $14K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 8,090 | $13K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 1,376 | $11K |
| 84484 | <1% | 10,736 | $10K | |
| 87040 | <1% | 207 | $10K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 2,315 | $8K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 2,970 | $7K |
| 93971 | <1% | 53 | $7K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 250 | $5K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 119 | $4K |
| 71045 | Radiologic examination, chest; single view | <1% | 3,253 | $3K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 42 | $3K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 616 | $3K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 4,064 | $2K |
| 82553 | <1% | 2,510 | $2K | |
| 82962 | <1% | 3,697 | $2K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 5,499 | $2K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 16 | $2K |
| 73564 | <1% | 114 | $2K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 277 | $1K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 58 | $1K |
| 81001 | <1% | 3,383 | $1K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 159 | $1K |
| 84702 | <1% | 499 | $1K | |
| 87077 | <1% | 64 | $1K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 218 | $1K |
| 82550 | <1% | 2,790 | $1K | |
| 83690 | <1% | 3,169 | $994.79 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 419 | $991.85 |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 1,272 | $970.96 |
| 87088 | <1% | 978 | $933.67 | |
| 87210 | <1% | 14 | $906.53 | |
| 81025 | <1% | 327 | $890.62 | |
| 81003 | <1% | 1,535 | $839.57 | |
| 73030 | <1% | 44 | $804.69 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,726 | $714.27 |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 25 | $677.21 |
| 97165 | <1% | 30 | $653.34 | |
| 83605 | <1% | 712 | $647.05 | |
| 83880 | <1% | 1,140 | $640.18 | |
| 73630 | <1% | 14 | $620.83 | |
| 83735 | <1% | 3,852 | $606.93 | |
| 87486 | <1% | 259 | $587.18 | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 257 | $542.29 |
| 73610 | <1% | 12 | $531.18 | |
| J2704 | Injection, propofol, 10 mg | <1% | 1,524 | $516.11 |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 250 | $491.64 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 2,026 | $435.63 |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 39 | $403.17 |
| 85610 | <1% | 2,302 | $398.72 | |
| 93307 | <1% | 51 | $362.57 | |
| 84145 | <1% | 14 | $347.79 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 666 | $347.31 |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 532 | $314.33 |
| 85730 | <1% | 898 | $296.52 | |
| 86850 | <1% | 440 | $263.01 | |
| 87581 | <1% | 250 | $254.69 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 3,316 | $220.62 |
| 93041 | <1% | 1,030 | $209.94 | |
| 80061 | Lipid panel | <1% | 79 | $196.42 |
| 85378 | <1% | 495 | $195.23 | |
| 0223U | <1% | 21 | $160.38 | |
| 86900 | <1% | 686 | $159.32 | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 335 | $145.76 |
| 87631 | <1% | 29 | $141.07 | |
| 97166 | <1% | 13 | $129.57 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 358 | $129.55 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,197 | $115.82 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 459 | $106.32 |
| 86901 | <1% | 466 | $89.07 | |
| 85027 | <1% | 240 | $76.97 | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 37 | $52.77 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 1,355 | $30.96 |
| J1630 | Injection, haloperidol, up to 5 mg | <1% | 15 | $23.78 |
| 94760 | <1% | 53 | $23.11 | |
| 87186 | <1% | 53 | $21.66 | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 35 | $16.16 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 137 | $12.55 |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 783 | $11.92 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 365 | $8.49 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 315 | $7.04 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 107 | $5.83 |
| 84100 | <1% | 63 | $3.54 | |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | <1% | 39 | $0.05 |
| 81015 | 0% | 211 | $0.00 | |
| 82077 | 0% | 111 | $0.00 | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 0% | 227 | $0.00 |
| 97535 | Self-care/home management training, each 15 minutes | 0% | 40 | $0.00 |
| 36415 | Collection of venous blood by venipuncture | 0% | 22 | $0.00 |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 0% | 14 | $0.00 |
| 87400 | 0% | 23 | $0.00 | |
| 97161 | 0% | 124 | $0.00 | |
| 72125 | Computed tomography, cervical spine; without contrast material | 0% | 109 | $0.00 |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | 0% | 256 | $0.00 |
| J3475 | Injection, magnesium sulfate, per 500 mg | 0% | 49 | $0.00 |
| 93798 | 0% | 270 | $0.00 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 0% | 41 | $0.00 |
| 80179 | 0% | 12 | $0.00 | |
| 80143 | 0% | 12 | $0.00 | |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Kona Hospital | Kealakekua, HI | $22.27M |
| Adventist Healthcare, INC. | Silver Spring, MD | $4.50M |
| Adventist Healthcare Urgent Care Centers INC | Rockville, MD | $1.56M |
| Pure Dental, PC | Flushing, NY | $1.24M |
| Access Home Medical LLC | Sumter, SC | $520K |
| Adventist Rehabilitation Hospital of Maryland INC | Rockville, MD | $470K |
| James Lee MD PC | Colorado Springs, CO | $450K |
| Peak Surgery Center LLC | Colorado Springs, CO | $36K |
| Ascension Behavioral Healthcare, P.A. | Rock Hill, SC | $23K |
| Heartcare, PC | Cullman, AL | $8K |
| DR Keith Lee-Integrative Mental Health, LLC | Owensboro, KY | $6K |
| Ent & Allergy Specialists of Virginia PC | Ashburn, VA | $1K |
| Outpatient Biopsy Center | Alhambra, CA | $430.63 |
| Adventist Healthcare, INC. | Rockville, MD | $0.00 |
| Vascular Center of Intervention, INC. | Fresno, CA | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.